News

Intermittent hypoxemia linked to disability at 18 months

View on the News

Changes in therapy not yet warranted

Interventions to minimize hypoxemic episodes in this patient population are not yet warranted. Any such strategies, including the use of doxapram or high-dose caffeine therapy suggested by Dr. Poets and his associates, must first be evaluated in rigorous randomized clinical trials with long-term developmental outcome as the primary endpoint.

It is critical to minimize the exposure of these high-risk patients to therapies that may be useless or even harmful. Neonatal intensive care is littered with examples of treatments that were introduced based on observational data, only to be proven disastrous when tested properly in RCTs.

For now, well-tested treatments to improve developmental outcomes in extremely preterm infants, such as magnesium sulfate before birth, regular doses of caffeine, or developmental care interventions after discharge, should be maximized.

Dr. Lex W. Doyle is with the department of obstetrics and gynecology at Royal Women’s Hospital in Parkville, Australia. He reported having no relevant financial conflicts of interest. Dr. Doyle made these remarks in an accompanying editorial (JAMA. 2015;314(6):568-9. doi: 10.1001/jama.2015.9136).


 

FROM JAMA

References

Intermittent episodes of hypoxemia lasting more than 1 minute during the first 2-3 months after extremely preterm birth are associated with severe disability at age 18 months, according to a report published online Aug. 11 in JAMA.

Almost all extremely preterm infants experience intermittent hypoxemia during their NICU stay, but the relationship between this hypoxemia and later neurodevelopmental problems is uncertain. To examine this issue, researchers performed a post-hoc analysis of data gathered in the multicenter Canadian Oxygen Trial, which compared the effects of lower (85%-89%) vs. higher (91%-95%) oxygen saturation targets in preterm infants. The post-hoc study focused on 1,019 infants born at 23-27 weeks’ gestation who survived to 36 weeks’ postmenstrual age, said Dr. Christian F. Poets of the department of neonatology at Tuebingen (Germany) University Hospital and his associates.

©Fuse/Thinkstock.com

The investigators assessed whether hypoxemia correlated with the composite outcome of death after 36 weeks’ postmenstrual age or disability – motor impairment, cognitive or language delay, severe hearing loss requiring hearing aids or cochlear implants, bilateral blindness, or severe retinopathy of prematurity – assessed at a corrected age of 18 months. These adverse outcomes occurred in 43% of the study population.

The mean percentage of time with hypoxemia ranged from 0.4% in the lowest decile to 13.5% in the highest. The probability of each adverse outcome increased significantly as the percentage of time in hypoxemia increased. For the primary outcome of late death or disability, the relative risk was 1.53 among infants in the highest vs. the lowest decile. Stated another way, hypoxemic episodes were associated with death or severe disability in 56.5% of infants in the highest decile of hypoxemia exposure, compared with only 36.9% of those in the lowest decile. Each individual adverse outcome also followed this pattern of risk, the investigators said (JAMA. 2015;314(6):595-603. doi: 10.1001/jama.2015.8841). Only prolonged episodes of hypoxemia lasting more than 1 minute were found to correlate with adverse outcomes; shorter episodes did not. The risk of adverse outcomes increased as age at the time of hypoxemia episodes increased, so that the greatest risk was observed in infants whose hypoxemia occurred 9-10 weeks after birth.

The post-hoc design of this study can only generate hypotheses for future research rather than determine definitive conclusions, so it is not yet known whether prolonged intermittent hypoxemia contributes to neurodevelopmental impairment or is just a feature that denotes which infants are destined to develop impairments. If future studies determine that hypoxemia is a cause of adverse outcomes, it may be a preventable cause – perhaps with caffeine therapy, specific ventilator strategies, or doxapram administration, Dr. Poets and his associates said.

This study was funded exclusively by the Canadian Institutes of Health Research. Dr. Poets reported receiving research grants from Chiesi Farmaceurici SpA and Masimo.

Recommended Reading

ACIP: Tdap during pregnancy optimal strategy for protecting infants
MDedge ObGyn
ACOG adds HPV-9 to vaccination advice
MDedge ObGyn
Cuba eliminates mother-to-child transmission of HIV, syphilis
MDedge ObGyn
More Medicaid-insured infants survive with enhanced prenatal care program
MDedge ObGyn
Preterm birth rate continues to drop
MDedge ObGyn
Fertility preservation more likely for young male cancer patients
MDedge ObGyn
Many doctors not advising on proper infant care
MDedge ObGyn
Joint Commission offers perinatal care certification
MDedge ObGyn
9-valent HPV vaccine equally effective in adolescents, young women
MDedge ObGyn
Intestinal obstruction risk increased in some childhood cancer survivors
MDedge ObGyn